A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...

The Archbishop of Cincinnati was hospitalized after he fell at his home due to neuropathy linked to his chemotherapy treatment, according to the Archdiocese of Cincinnati spokesperson Jennifer Schack.

A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a ...

The manufacturer of AV-101, an investigational, oral nonopioid, NMDA-targeting therapy to treat neuropathic pain, announced that it has received a U.S. patent for the treatment. AV-101 (4-Cl-KYN) is ...

A retrospective case series identified nine patients who developed ophthalmic complications during treatment with semaglutide ...

Neuropathy, a condition that affects individuals of all ages but is most common in older adults, often causes pain in the ...

A RETROSPECTIVE case series has identified ophthalmic complications in patients using the antidiabetic drugs semaglutide and ...

Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and ...

A small percentage have had vision problems, but a direct causal link with the drugs has not been established.

A lymphoma specialist who survived her own tumor surgery helps patients navigate the daunting decisions to be made.

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...